Medical Care

Global Autoimmune Disease Model Market Research Report 2025

The global market for Autoimmune Disease Model was valued at US$ 437 million in the year 2024 and is projected to reach a revised size of US$ 720 million by 2031, growing at a CAGR of 7.4% during the forecast period.
The autoimmune disease model is a research tool that simulates pathological features of human autoimmune diseases in experimental animals or in vitro systems through genetic modification, chemical induction, or immune intervention. This model reproduces core pathological processes such as aberrant immune activation, autoantigen-specific responses, and tissue-specific damage, providing a standardized experimental platform for elucidating pathogenesis, screening therapeutic targets, and evaluating intervention strategies.
North American market for Autoimmune Disease Model is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Autoimmune Disease Model is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Autoimmune Disease Model in Clinical Diagnosis is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Autoimmune Disease Model include Charles River Laboratories, The Jackson Laboratory, Oncodesign, Cyagen, Biospective, Atlantis Bioscience, Taconic Biosciences, Syngene International, Pharmalegacy, Shanghai Model Organisms Center, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Disease Model, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Disease Model.
The Autoimmune Disease Model market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autoimmune Disease Model market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Disease Model companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
The Jackson Laboratory
Oncodesign
Cyagen
Biospective
Atlantis Bioscience
Taconic Biosciences
Syngene International
Pharmalegacy
Shanghai Model Organisms Center, Inc.
Vitalstar Biotechnology Co.,Ltd.
Pharmalegacy Laboratories (Shanghai) Co., Ltd.
Beijing Viewsolid Biotechnology Co., Ltd.
GemPharmatech Co., Ltd.
Beijing Biocytogen Co., Ltd.
Segment by Type
SLE Model
AD Model
CIA Model
SS Model
Others
Segment by Application
Clinical Diagnosis
Scientific Research
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Disease Model company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Model Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 SLE Model
1.2.3 AD Model
1.2.4 CIA Model
1.2.5 SS Model
1.2.6 Others
1.3 Market by Application
1.3.1 Global Autoimmune Disease Model Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnosis
1.3.3 Scientific Research
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disease Model Market Perspective (2020-2031)
2.2 Global Autoimmune Disease Model Growth Trends by Region
2.2.1 Global Autoimmune Disease Model Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Autoimmune Disease Model Historic Market Size by Region (2020-2025)
2.2.3 Autoimmune Disease Model Forecasted Market Size by Region (2026-2031)
2.3 Autoimmune Disease Model Market Dynamics
2.3.1 Autoimmune Disease Model Industry Trends
2.3.2 Autoimmune Disease Model Market Drivers
2.3.3 Autoimmune Disease Model Market Challenges
2.3.4 Autoimmune Disease Model Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Model Players by Revenue
3.1.1 Global Top Autoimmune Disease Model Players by Revenue (2020-2025)
3.1.2 Global Autoimmune Disease Model Revenue Market Share by Players (2020-2025)
3.2 Global Top Autoimmune Disease Model Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Autoimmune Disease Model Revenue
3.4 Global Autoimmune Disease Model Market Concentration Ratio
3.4.1 Global Autoimmune Disease Model Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Model Revenue in 2024
3.5 Global Key Players of Autoimmune Disease Model Head office and Area Served
3.6 Global Key Players of Autoimmune Disease Model, Product and Application
3.7 Global Key Players of Autoimmune Disease Model, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disease Model Breakdown Data by Type
4.1 Global Autoimmune Disease Model Historic Market Size by Type (2020-2025)
4.2 Global Autoimmune Disease Model Forecasted Market Size by Type (2026-2031)
5 Autoimmune Disease Model Breakdown Data by Application
5.1 Global Autoimmune Disease Model Historic Market Size by Application (2020-2025)
5.2 Global Autoimmune Disease Model Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Autoimmune Disease Model Market Size (2020-2031)
6.2 North America Autoimmune Disease Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Autoimmune Disease Model Market Size by Country (2020-2025)
6.4 North America Autoimmune Disease Model Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autoimmune Disease Model Market Size (2020-2031)
7.2 Europe Autoimmune Disease Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Autoimmune Disease Model Market Size by Country (2020-2025)
7.4 Europe Autoimmune Disease Model Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Model Market Size (2020-2031)
8.2 Asia-Pacific Autoimmune Disease Model Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Autoimmune Disease Model Market Size by Region (2020-2025)
8.4 Asia-Pacific Autoimmune Disease Model Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Autoimmune Disease Model Market Size (2020-2031)
9.2 Latin America Autoimmune Disease Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Autoimmune Disease Model Market Size by Country (2020-2025)
9.4 Latin America Autoimmune Disease Model Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Model Market Size (2020-2031)
10.2 Middle East & Africa Autoimmune Disease Model Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Autoimmune Disease Model Market Size by Country (2020-2025)
10.4 Middle East & Africa Autoimmune Disease Model Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Details
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Autoimmune Disease Model Introduction
11.1.4 Charles River Laboratories Revenue in Autoimmune Disease Model Business (2020-2025)
11.1.5 Charles River Laboratories Recent Development
11.2 The Jackson Laboratory
11.2.1 The Jackson Laboratory Company Details
11.2.2 The Jackson Laboratory Business Overview
11.2.3 The Jackson Laboratory Autoimmune Disease Model Introduction
11.2.4 The Jackson Laboratory Revenue in Autoimmune Disease Model Business (2020-2025)
11.2.5 The Jackson Laboratory Recent Development
11.3 Oncodesign
11.3.1 Oncodesign Company Details
11.3.2 Oncodesign Business Overview
11.3.3 Oncodesign Autoimmune Disease Model Introduction
11.3.4 Oncodesign Revenue in Autoimmune Disease Model Business (2020-2025)
11.3.5 Oncodesign Recent Development
11.4 Cyagen
11.4.1 Cyagen Company Details
11.4.2 Cyagen Business Overview
11.4.3 Cyagen Autoimmune Disease Model Introduction
11.4.4 Cyagen Revenue in Autoimmune Disease Model Business (2020-2025)
11.4.5 Cyagen Recent Development
11.5 Biospective
11.5.1 Biospective Company Details
11.5.2 Biospective Business Overview
11.5.3 Biospective Autoimmune Disease Model Introduction
11.5.4 Biospective Revenue in Autoimmune Disease Model Business (2020-2025)
11.5.5 Biospective Recent Development
11.6 Atlantis Bioscience
11.6.1 Atlantis Bioscience Company Details
11.6.2 Atlantis Bioscience Business Overview
11.6.3 Atlantis Bioscience Autoimmune Disease Model Introduction
11.6.4 Atlantis Bioscience Revenue in Autoimmune Disease Model Business (2020-2025)
11.6.5 Atlantis Bioscience Recent Development
11.7 Taconic Biosciences
11.7.1 Taconic Biosciences Company Details
11.7.2 Taconic Biosciences Business Overview
11.7.3 Taconic Biosciences Autoimmune Disease Model Introduction
11.7.4 Taconic Biosciences Revenue in Autoimmune Disease Model Business (2020-2025)
11.7.5 Taconic Biosciences Recent Development
11.8 Syngene International
11.8.1 Syngene International Company Details
11.8.2 Syngene International Business Overview
11.8.3 Syngene International Autoimmune Disease Model Introduction
11.8.4 Syngene International Revenue in Autoimmune Disease Model Business (2020-2025)
11.8.5 Syngene International Recent Development
11.9 Pharmalegacy
11.9.1 Pharmalegacy Company Details
11.9.2 Pharmalegacy Business Overview
11.9.3 Pharmalegacy Autoimmune Disease Model Introduction
11.9.4 Pharmalegacy Revenue in Autoimmune Disease Model Business (2020-2025)
11.9.5 Pharmalegacy Recent Development
11.10 Shanghai Model Organisms Center, Inc.
11.10.1 Shanghai Model Organisms Center, Inc. Company Details
11.10.2 Shanghai Model Organisms Center, Inc. Business Overview
11.10.3 Shanghai Model Organisms Center, Inc. Autoimmune Disease Model Introduction
11.10.4 Shanghai Model Organisms Center, Inc. Revenue in Autoimmune Disease Model Business (2020-2025)
11.10.5 Shanghai Model Organisms Center, Inc. Recent Development
11.11 Vitalstar Biotechnology Co.,Ltd.
11.11.1 Vitalstar Biotechnology Co.,Ltd. Company Details
11.11.2 Vitalstar Biotechnology Co.,Ltd. Business Overview
11.11.3 Vitalstar Biotechnology Co.,Ltd. Autoimmune Disease Model Introduction
11.11.4 Vitalstar Biotechnology Co.,Ltd. Revenue in Autoimmune Disease Model Business (2020-2025)
11.11.5 Vitalstar Biotechnology Co.,Ltd. Recent Development
11.12 Pharmalegacy Laboratories (Shanghai) Co., Ltd.
11.12.1 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Company Details
11.12.2 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Business Overview
11.12.3 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Autoimmune Disease Model Introduction
11.12.4 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Revenue in Autoimmune Disease Model Business (2020-2025)
11.12.5 Pharmalegacy Laboratories (Shanghai) Co., Ltd. Recent Development
11.13 Beijing Viewsolid Biotechnology Co., Ltd.
11.13.1 Beijing Viewsolid Biotechnology Co., Ltd. Company Details
11.13.2 Beijing Viewsolid Biotechnology Co., Ltd. Business Overview
11.13.3 Beijing Viewsolid Biotechnology Co., Ltd. Autoimmune Disease Model Introduction
11.13.4 Beijing Viewsolid Biotechnology Co., Ltd. Revenue in Autoimmune Disease Model Business (2020-2025)
11.13.5 Beijing Viewsolid Biotechnology Co., Ltd. Recent Development
11.14 GemPharmatech Co., Ltd.
11.14.1 GemPharmatech Co., Ltd. Company Details
11.14.2 GemPharmatech Co., Ltd. Business Overview
11.14.3 GemPharmatech Co., Ltd. Autoimmune Disease Model Introduction
11.14.4 GemPharmatech Co., Ltd. Revenue in Autoimmune Disease Model Business (2020-2025)
11.14.5 GemPharmatech Co., Ltd. Recent Development
11.15 Beijing Biocytogen Co., Ltd.
11.15.1 Beijing Biocytogen Co., Ltd. Company Details
11.15.2 Beijing Biocytogen Co., Ltd. Business Overview
11.15.3 Beijing Biocytogen Co., Ltd. Autoimmune Disease Model Introduction
11.15.4 Beijing Biocytogen Co., Ltd. Revenue in Autoimmune Disease Model Business (2020-2025)
11.15.5 Beijing Biocytogen Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Autoimmune Disease Model Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of SLE Model
Table 3. Key Players of AD Model
Table 4. Key Players of CIA Model
Table 5. Key Players of SS Model
Table 6. Key Players of Others
Table 7. Global Autoimmune Disease Model Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Autoimmune Disease Model Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Autoimmune Disease Model Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Autoimmune Disease Model Market Share by Region (2020-2025)
Table 11. Global Autoimmune Disease Model Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Autoimmune Disease Model Market Share by Region (2026-2031)
Table 13. Autoimmune Disease Model Market Trends
Table 14. Autoimmune Disease Model Market Drivers
Table 15. Autoimmune Disease Model Market Challenges
Table 16. Autoimmune Disease Model Market Restraints
Table 17. Global Autoimmune Disease Model Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Autoimmune Disease Model Market Share by Players (2020-2025)
Table 19. Global Top Autoimmune Disease Model Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Disease Model as of 2024)
Table 20. Ranking of Global Top Autoimmune Disease Model Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Autoimmune Disease Model Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Autoimmune Disease Model, Headquarters and Area Served
Table 23. Global Key Players of Autoimmune Disease Model, Product and Application
Table 24. Global Key Players of Autoimmune Disease Model, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Autoimmune Disease Model Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Autoimmune Disease Model Revenue Market Share by Type (2020-2025)
Table 28. Global Autoimmune Disease Model Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Autoimmune Disease Model Revenue Market Share by Type (2026-2031)
Table 30. Global Autoimmune Disease Model Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Autoimmune Disease Model Revenue Market Share by Application (2020-2025)
Table 32. Global Autoimmune Disease Model Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Autoimmune Disease Model Revenue Market Share by Application (2026-2031)
Table 34. North America Autoimmune Disease Model Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Autoimmune Disease Model Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Autoimmune Disease Model Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Autoimmune Disease Model Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Autoimmune Disease Model Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Autoimmune Disease Model Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Autoimmune Disease Model Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Autoimmune Disease Model Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Autoimmune Disease Model Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Autoimmune Disease Model Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Autoimmune Disease Model Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Autoimmune Disease Model Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Autoimmune Disease Model Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Autoimmune Disease Model Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Autoimmune Disease Model Market Size by Country (2026-2031) & (US$ Million)
Table 49. Charles River Laboratories Company Details
Table 50. Charles River Laboratories Business Overview
Table 51. Charles River Laboratories Autoimmune Disease Model Product
Table 52. Charles River Laboratories Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 53. Charles River Laboratories Recent Development
Table 54. The Jackson Laboratory Company Details
Table 55. The Jackson Laboratory Business Overview
Table 56. The Jackson Laboratory Autoimmune Disease Model Product
Table 57. The Jackson Laboratory Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 58. The Jackson Laboratory Recent Development
Table 59. Oncodesign Company Details
Table 60. Oncodesign Business Overview
Table 61. Oncodesign Autoimmune Disease Model Product
Table 62. Oncodesign Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 63. Oncodesign Recent Development
Table 64. Cyagen Company Details
Table 65. Cyagen Business Overview
Table 66. Cyagen Autoimmune Disease Model Product
Table 67. Cyagen Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 68. Cyagen Recent Development
Table 69. Biospective Company Details
Table 70. Biospective Business Overview
Table 71. Biospective Autoimmune Disease Model Product
Table 72. Biospective Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 73. Biospective Recent Development
Table 74. Atlantis Bioscience Company Details
Table 75. Atlantis Bioscience Business Overview
Table 76. Atlantis Bioscience Autoimmune Disease Model Product
Table 77. Atlantis Bioscience Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 78. Atlantis Bioscience Recent Development
Table 79. Taconic Biosciences Company Details
Table 80. Taconic Biosciences Business Overview
Table 81. Taconic Biosciences Autoimmune Disease Model Product
Table 82. Taconic Biosciences Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 83. Taconic Biosciences Recent Development
Table 84. Syngene International Company Details
Table 85. Syngene International Business Overview
Table 86. Syngene International Autoimmune Disease Model Product
Table 87. Syngene International Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 88. Syngene International Recent Development
Table 89. Pharmalegacy Company Details
Table 90. Pharmalegacy Business Overview
Table 91. Pharmalegacy Autoimmune Disease Model Product
Table 92. Pharmalegacy Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 93. Pharmalegacy Recent Development
Table 94. Shanghai Model Organisms Center, Inc. Company Details
Table 95. Shanghai Model Organisms Center, Inc. Business Overview
Table 96. Shanghai Model Organisms Center, Inc. Autoimmune Disease Model Product
Table 97. Shanghai Model Organisms Center, Inc. Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 98. Shanghai Model Organisms Center, Inc. Recent Development
Table 99. Vitalstar Biotechnology Co.,Ltd. Company Details
Table 100. Vitalstar Biotechnology Co.,Ltd. Business Overview
Table 101. Vitalstar Biotechnology Co.,Ltd. Autoimmune Disease Model Product
Table 102. Vitalstar Biotechnology Co.,Ltd. Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 103. Vitalstar Biotechnology Co.,Ltd. Recent Development
Table 104. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Company Details
Table 105. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Business Overview
Table 106. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Autoimmune Disease Model Product
Table 107. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 108. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Recent Development
Table 109. Beijing Viewsolid Biotechnology Co., Ltd. Company Details
Table 110. Beijing Viewsolid Biotechnology Co., Ltd. Business Overview
Table 111. Beijing Viewsolid Biotechnology Co., Ltd. Autoimmune Disease Model Product
Table 112. Beijing Viewsolid Biotechnology Co., Ltd. Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 113. Beijing Viewsolid Biotechnology Co., Ltd. Recent Development
Table 114. GemPharmatech Co., Ltd. Company Details
Table 115. GemPharmatech Co., Ltd. Business Overview
Table 116. GemPharmatech Co., Ltd. Autoimmune Disease Model Product
Table 117. GemPharmatech Co., Ltd. Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 118. GemPharmatech Co., Ltd. Recent Development
Table 119. Beijing Biocytogen Co., Ltd. Company Details
Table 120. Beijing Biocytogen Co., Ltd. Business Overview
Table 121. Beijing Biocytogen Co., Ltd. Autoimmune Disease Model Product
Table 122. Beijing Biocytogen Co., Ltd. Revenue in Autoimmune Disease Model Business (2020-2025) & (US$ Million)
Table 123. Beijing Biocytogen Co., Ltd. Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report


List of Figures
Figure 1. Autoimmune Disease Model Picture
Figure 2. Global Autoimmune Disease Model Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Autoimmune Disease Model Market Share by Type: 2024 VS 2031
Figure 4. SLE Model Features
Figure 5. AD Model Features
Figure 6. CIA Model Features
Figure 7. SS Model Features
Figure 8. Others Features
Figure 9. Global Autoimmune Disease Model Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Autoimmune Disease Model Market Share by Application: 2024 VS 2031
Figure 11. Clinical Diagnosis Case Studies
Figure 12. Scientific Research Case Studies
Figure 13. Others Case Studies
Figure 14. Autoimmune Disease Model Report Years Considered
Figure 15. Global Autoimmune Disease Model Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Autoimmune Disease Model Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Autoimmune Disease Model Market Share by Region: 2024 VS 2031
Figure 18. Global Autoimmune Disease Model Market Share by Players in 2024
Figure 19. Global Autoimmune Disease Model Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Autoimmune Disease Model Revenue in 2024
Figure 21. North America Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Autoimmune Disease Model Market Share by Country (2020-2031)
Figure 23. United States Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Autoimmune Disease Model Market Share by Country (2020-2031)
Figure 27. Germany Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Autoimmune Disease Model Market Share by Region (2020-2031)
Figure 35. China Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Autoimmune Disease Model Market Share by Country (2020-2031)
Figure 43. Mexico Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Autoimmune Disease Model Market Share by Country (2020-2031)
Figure 47. Israel Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Autoimmune Disease Model Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Charles River Laboratories Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 51. The Jackson Laboratory Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 52. Oncodesign Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 53. Cyagen Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 54. Biospective Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 55. Atlantis Bioscience Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 56. Taconic Biosciences Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 57. Syngene International Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 58. Pharmalegacy Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 59. Shanghai Model Organisms Center, Inc. Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 60. Vitalstar Biotechnology Co.,Ltd. Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 61. Pharmalegacy Laboratories (Shanghai) Co., Ltd. Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 62. Beijing Viewsolid Biotechnology Co., Ltd. Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 63. GemPharmatech Co., Ltd. Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 64. Beijing Biocytogen Co., Ltd. Revenue Growth Rate in Autoimmune Disease Model Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies